We want to confirm we have your most updated contact information and make sure you are fully set up and linked to our Coupa account.

We conducted this verification independently and to our knowledge there has been no conflict of interest. We consent to the release of this declaration by you to the public or other organizations but without accepting or assuming any responsibility or liability on our part to any other party who may have access to this declaration.

We conducted this verification independently and to our knowledge there has been no conflict of interest. We consent to the release of this declaration by you to CDP in order to satisfy the terms of CDP disclosure requirements but without accepting or assuming any responsibility or liability on our part to CDP or to any other party who may have access to this declaration.

We believe outdoor enthusiasts share an astonishing passion for nature, even when the path they take to immerse themselves in their surroundings varies a great deal. That’s where we come in, helping you bring each individual to their outdoor paradise.

Engineered Polymer Formulations for Firearm Components At Avient, we focus on solving your material science challenges. From custom solutions to innovative design, we understand how to integrate specialty materials into your projects to create reliable and comfortable products that deliver outstanding performance and a remarkable customer experience.

INDUSTRY BULLETIN DISPERSIONS IN HEALTHCARE TECHNOLOGY DESCRIPTION TYPICAL APPLICATIONS Silicone Colorant Dispersions Biocompatible, conformable silicone rubber colorants that deliver lightfastness and aesthetic appeal • 3D medical silicone printing • Anatomical models and surgical guides • External prosthetics and orthotics • Medical ventilation/respiratory masks • Dental and medical tools and equipment Silicone Additive Dispersions Silicone additive solutions formulated to provide chemical resistance, durability, and enhanced physical properties Rubber Colorant Dispersions Durable rubber colorants formulated for optimal dispersion and lot-to-lot consistency to promote ease of handling • Medical devices and tools • Vibration and shock control for medical equipment • Drug delivery devices Urethane Colorant Dispersions Versatile urethane colorants that streamline production and enhance quality • Foam enclosures/support for medical tools and equipment • Medical and surgical devices • Physical therapy tools Epoxy Colorant Dispersions Long-lasting, hygienic epoxy colorants that provide high-cost efficiency, stability, and customization opportunities • Healthcare facility floor coatings Vinyl Colorant Dispersions Vinyl colorants developed for applications where dispersion, uniformity, compatibility, and cleanliness are essential • Medical equipment Aqueous Additive Formulations Functional additives stabilized, suspended, and dispersed in water that shorten development cycles, streamline operations, and can be customized to meet specific requirements • Medical gloves • Wound care Electrically Conductive Additives for Silicone Innovative silicone additives to provide high conductivity and lower filler loadings • Neurostimulation electrode pads • Medical tools and equipment Laser Marking Additives for Silicone Dispersions containing laser absorbers and color formers that eliminate the need for secondary etching while promoting chemical resistance, mechanical property retention, and production efficiency • 3D medical silicone printing • Anatomical models and surgical guides • External prosthetics and orthotics • Medical ventilation/respiratory masks • Medical devices Surface Modification Additives for Silicone Non-oil based silicone additives that reduce tackiness and enhance smoothness of the cured compound • Dental tools and equipment • Medical devices, tools, and equipment Self-Bonding Silicone Silicone compounds able to bond to various substrates without prime coating • Medical tools and equipment This listing represents standard Avient dispersion technologies and addresses common healthcare applications, but we can work with you to explore additional options. From silicone colorants pre-tested for USP Class VI compliance to additives that effectively streamline production, we have dispersion technologies that can address your challenges.

Factor Median Peer Group Comparator 2017 Financials* 2018 PolyOne Results PolyOne Peer Group for 2018 Compensation Decisions Review of 2018 Named Executive Officer Compensation What We Pay and Why: Elements of Compensation 2018 Base Salary 2018 Annual Incentive. Exercise or Base Price of Option Awards (column (i)) Grant Date Fair Value of Stock and Option Awards (column (j)) Narrative Disclosure Relating to the 2018 Summary Compensation Table and the 2018 Grants of Plan-Based Awards Table Outstanding Equity Awards at 2018 Fiscal Year-End Exercise Price Expiration Date Market Value of Shares or Units of Stock That Have Not Vested Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested (j) Stock Awards Equity Incentive Plan Awards: Number of Securities Underlying Unearned Options Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (i) Number of Shares or Units of Stock That Have Not Vested Number of Underlying Unexercised Options (#) Unexercisable Number of Securities Underlying Options (#) Exercisable Option Awards Number of Securities Underlying Unexercised Options (#) Exercisable (column (b)) Number of Securities Underlying Unexercised Options (#) Unexercisable (column (c)) Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (column (d)) Option Exercise Price (column (e)) Option Expiration Date (column (f)) Number of Shares or Units of Stock That Have Not Vested (column (g)) Market Value of Shares or Units of Stock That Have Not Vested (column (h)) Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (column (i)) Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested (column (j)) 2018 Option Exercises and Stock Vested Option Awards Stock Awards Acquired on Exercise Value Realized on Exercise Acquired on Vesting Value Realized on Vesting Option Awards (columns (b) and (c)) Stock Awards (columns (d) and (e)) 2018 Nonqualified Deferred Compensation Aggregate Executive Registrant Aggregate Aggregate Aggregate Balance at Contributions Contributions Earnings Withdrawals/ Balance at in Last FY in Last FY in Last FY Distributions Last FYE (1) ($)(2) ($)(3) ($)(4) ($) ($)(1)(5) Potential Payments Upon Termination or Change of Control Summary of Potential Payments Management Continuity Agreements Executive Severance Plan Annual Plan Long-Term Incentive Awards Retirement Benefits Payments and Benefits Upon Termination — As of the End of Fiscal Year 2018 CEO Pay Ratio Disclosure CEO Annual Total Compensation for 2018: $6,127,920 Median Employee Annual Total Compensation for 2018: $48,056 Ratio of CEO to Median Employee Annual Total Compensation for 2018: 128:1 How the Median Employee was Determined in 2017 Compensation Committee Interlocks and Insider Participation Policy on Related Person Transactions Risk Assessment of the Compensation Programs Compensation Committee Report The Compensation Committee of the Board of Directors MISCELLANEOUS MISCELLANEOUS PROVISIONS Voting at the Meeting not Shareholder Proposals MISCELLANEOUS Proxy Solicitation We will furnish without charge to each person from whom a proxy is being solicited, upon written request of any such person, a copy of the Annual Report on Form 10-K of the Company for the fiscal year ending December 31, 2018, as filed with the SEC, including the financial statements and schedules thereto. Kunkle APPENDIX A Year Ended Year Ended December 31, 2018 December 31, 2017 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Year Ended Year Ended December 31, 2016 December 31, 2015 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Year Ended December 31, 2014 Reconciliation to Condensed Consolidated Statements of Income $ EPS Year Ended December 31, Reconciliation to Consolidated Statements of Income 2018 2017 As of December 31, 2018 Table Of Contents Message From Our CEO Notice Of 2019 Annual Meeting Of Shareholders Proxy Summary Proxy Statement Proposal 1-Election Of Board Of Directors Proposal 2-Advisory Vote To Approve Named Executive Officer Compensation Proposal 3-Ratification Of Appointment Of Independent Registered Public Accounting Firm Corporate Governance 2018 Non-employee Director Compensation Ownership Of Polyone Shares Compensation Discussion And Analysis Executive Summary Executive Compensation Philosophy And Objectives What We Pay And Why: Elements Of Compensation Other Aspects Of Our Compensation Programs Executive Compensation 2018 Summary Compensation Table 2018 Grants Of Plan-Based Awards Outstanding Equity Awards At 2018 Fiscal Year-End 2018 Option Exercises And Stock Vested 2018 Nonqualified Deferred Compensation Potential Payments Upon Termination Or Change Of Control CEO Pay Ratio Disclosure Compensation Committee Interlocks And Insider Participation Policy On Related Person Transactions Risk Assessment Of The Compensation Programs Compensation Committee Report Miscellaneous Provisions Appendix A

Hi-Tech Park Pudong, Shanghai 201203 China Phone: +86 (0) 21 5080 1188 E-mail: shanghai@polyone.com.cn That is our mission at PolyOne, and we fulfill it by delivering premium-quality products and services, which our customers use to enhance their own products. We believe no competitor can match our technical expertise because no workforce can outperform the people of PolyOne. We believe no competitor can match our technical expertise because no workforce can outperform the people of PolyOne.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • The time required to consummate the proposed acquisitions described in this presentation; • The satisfaction or waiver of conditions in the purchase agreements for the proposed acquisitions; • Any material adverse changes in the business of Clariant’s Color and Additive Masterbatch business; • The ability to obtain required regulatory or other third-party approvals and consents and otherwise consummate the proposed acquisitions; • Our ability to achieve the strategic and other objectives relating to the proposed acquisitions, including any expected synergies; • Our ability to successfully integrate Clariant’s Color and Additive Masterbatch business and achieve the expected results of the acquisitions, including, without limitation, the acquisitions being accretive; • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; • Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • An inability to raise or sustain prices for products or services; • An ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisition and integration, working capital reductions, costs reductions and employee productivity goals; • Information systems failures and cyberattacks; and • Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.

We intend to reduce the use of this substance at the facility. We intend to reduce the use of this substance at the facility. We intend to reduce the use of this substance at the facility.